Andreas-Claudius Hoffmann
Group Leader
Department of Medicine (Cancer Research)
West German Cancer Center
University Duisburg-Essen
Essen
Name/email consistency: high
- MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Hoffmann, A.C., Wild, P., Leicht, C., Bertz, S., Danenberg, K.D., Danenberg, P.V., Stöhr, R., Stöckle, M., Lehmann, J., Schuler, M., Hartmann, A. Neoplasia (2010)
- Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. Hoffmann, A.C., Vallböhmer, D., Prenzel, K., Metzger, R., Heitmann, M., Neiss, S., Ling, F., Hölscher, A.H., Schneider, P.M., Brabender, J. J. Cancer Res. Clin. Oncol. (2009)
- A three-gene signature for outcome in soft tissue sarcoma. Hoffmann, A.C., Hoffman, A.C., Danenberg, K.D., Taubert, H., Danenberg, P.V., Wuerl, P. Clin. Cancer Res. (2009)
- High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. Hoffmann, A.C., Mori, R., Vallbohmer, D., Brabender, J., Drebber, U., Baldus, S.E., Klein, E., Azuma, M., Metzger, R., Hoffmann, C., Hoelscher, A.H., Danenberg, K.D., Prenzel, K.L., Danenberg, P.V. J. Gastrointest. Surg. (2008)
- High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Hoffmann, A.C., Mori, R., Vallbohmer, D., Brabender, J., Klein, E., Drebber, U., Baldus, S.E., Cooc, J., Azuma, M., Metzger, R., Hoelscher, A.H., Danenberg, K.D., Prenzel, K.L., Danenberg, P.V. Neoplasia (2008)